18F-FDG, as a single imaging agent in assessing cancer, shows the ongoing biological phenomena in many domains: Do we need additional tracers for clinical purposes?

Kwee, Thomas C.; Gholami, Saeid; Werner, Thomas J.; Rubello, Domenico; Alavi, Abass; Høilund-Carlsen, Poul F.

doi:https://doi.org/10.1097/MNM.0000000000000478

18F-FDG, as a single imaging agent in assessing cancer, shows the ongoing biological phenomena in many domains: Do we need additional tracers for clinical purposes?

DSpace/Manakin Repository

18F-FDG, as a single imaging agent in assessing cancer, shows the ongoing biological phenomena in many domains: Do we need additional tracers for clinical purposes?

Kwee, Thomas C.; Gholami, Saeid; Werner, Thomas J.; Rubello, Domenico; Alavi, Abass; Høilund-Carlsen, Poul F.

(2016) Nuclear Medicine Communications, volume 37, issue 4, pp. 333 - 337

(Editorial)

Download/Full Text

The full text of this publication is not available.

Version on publisher website for UU-students and staff

Version on publisher website

Keywords: Radiology Nuclear Medicine and imaging, Editorial

DOI: https://doi.org/10.1097/MNM.0000000000000478

ISSN: 0143-3636

Publisher: Lippincott Williams and Wilkins

(Peer reviewed)